Reconstructive surgery using autologous vessels is the conventional approach for substitution of diseased vessels or for generation of bypass to improve blood supply downstream of stenosed vessels. In some circumstances the use of autologous material is not possible due to concomitant diseases or previous use, and artificial grafts must be used. Unfortunately, these grafts cannot substitute small-caliber arterial vessels because of thrombotic complications. The objective of tissue engineering at the vascular level is then to generate biological substitutes of arterial conduits with functional characteristics of native vessels, combining cellular components with biodegradable scaffolds. These research projects started in several laboratories, in the late 1990s, and have expanded in different directions using a number of experimental approaches. The objective of this review is to give an overview of the results so far obtained in this area of research, and to discuss the problems related to these investigations, at the experimental and clinical level. The article provides an overview of different biodegradable scaffolds used, experimental techniques for vessels maturation in vitro under mechanical stimulation, and of differentiated as well as precursors of vascular cells, which opens new opportunities for further development of this form of cell transplantation. Finally, the current available results in clinical research will be discussed.
INTRODUCTION
a biological vascular substitute using tissue engineering techniques. These grafts must in principle be infection resistant, biocompatible, and nonthrombogenic. In addi-Cardiovascular diseases (CVD) are the leading cause of mortality in Western countries. In the US 38% of all tion, they must have mechanical properties matching those of native vessels with the ability to respond to deaths are related to CVD (2) . Conventional therapeutic strategies of CVD include angioplasty, with or without physiological stimuli, with vasoactive response, and structure remodeling consequent to environmental modi-stent application, and endoarterectomy or bypass grafting when the occlusion degree of the vessel is more se-fications (Table 1) . Tissue engineering (TE) is a multidisciplinary ap-vere (11). The graft usually consists of either artery or vein segments harvested from the patient. The supply of proach to provide living tissue products to restore, maintain, or improve tissue functions (17). For generation of healthy native vessels, however, is limited by the preexistence of pathological conditions or by previous surgi-connective tissue substitutes in vitro, cells are seeded onto a biodegradable material (scaffold) and the con-cal intervention. Moreover, the use of a venous tract in the arterial circulation often results in a process of vessel struct is developed with biochemical and biomechanical stimulation, to enable cells to remodel the scaffold and remodeling, with neointimal thickening that can lead to vessel stenosis or aneurysm formation (1) . Artificial vas-to produce extracellular matrix (ECM). Pioneering work on vascular tissue engineering cular grafts (such as Dacron fabric or expanded polytetrafluoroethylene) are now conventionally used for large started in the late 1980s with the study published by Weinberg and Bell (37) , but the first remarkable results arteries but are not suitable for small-caliber vessels, smaller than 6 mm in diameter (15).The occlusion of were those of L'Hereux and coworkers in 1998 (18). In their work, a tissue engineered blood vessel (TEBV) was these grafts may be caused by thrombus formation or, at longer time periods, by intimal hyperplasia, particularly produced, with human cells and without a support material. Human umbilical vein, smooth muscle cells (SMC), near anastomosis sites, that rapidly leads to graft occlusion (10). To overcome this limitation, several research and skin fibroblasts were grown in culture in the presence of sodium ascorbate, to induce ECM formation. groups focused in the last 10 years on the generation of After 30 days cells formed cohesive sheets that were and coworkers (14). They used a decellularized vascular vessel prepared from porcine iliac arteries as scaffold, removed from culture flasks. The SMC sheet was wrapped around a mandrel to produce the media of the and seeded the material with endothelial progenitor cells (EPC). Cells were isolated from peripheral blood of a vessel; after a week of maturation, the fibroblast sheet was rolled around the media to provide the adventitia sheep using a density gradient and then grown in culture for 7 weeks, before seeding. After having obtained a layer and then the construct was left in culture for 7 weeks. The mechanical properties of the TEBV were confluent endothelial layer, the grafts were subjected to shear stress preconditioning, to enhance cell retention. higher than that of human saphenous vein, with morphology of wall organization comparable to that of na-Nitric oxide production by EPC was assessed to verify the ability of fluid perfusion through the seeded grafts tive arteries. This layered vascular construct was implanted in dogs, showing good suturability and no sings to relax aorta segments previously contracted. The engineered vessels were implanted in vivo and remained pa-of degradation or dilatation after 7 days of implantation. On the other hand, intramural blood infiltration was ob-tent for up to 130 days. At the time of harvest, however, some degree of intimal thickening of the grafts was ob-served between vessel layers. Long-term patency could not be verified in this study because of the lack of an served, due to host cells infiltration. These first results demonstrated the feasibility of endothelial lining.
In 1999 Niklason and coworkers (23) described the these experimental approaches but they seem to be time consuming, requiring more than 8 weeks in some in-development of a TEBV, based on bovine SMC and endothelial cells (EC), seeded onto a polyglicolic acid stance for vessel maturation. Another drawback of these techniques regards mechanical properties of the scaffold (PGA) mesh. The construct formed by SMC on the scaffold was cultured for 8 weeks in a bioreactor, to expose that are far from being elastic, like native vessels. Another important limitation of these studies is that the use the vessel lumen to a pulsatile pressure (165 bpm, 5% radial distention), through a silicon sleeve. Three days of differentiated vascular SMC and EC cells from autologous vascular tissue requires harvesting an arterial or before harvesting, the sleeve was removed and the lumen of the vessel was seeded with endothelial cells, then venous vessel segment from the patient. Present research lines focus on these aspects, trying to find a solution that medium flow was applied directly to the cultured vessel. Histology of the TEBV showed the construct wall ho-can lead to improved engineered vascular prostheses. In the following we discuss the research activities in this mogeneously colonized by SMCs, with few PGA residues. These vessels also displayed contractions in re-context that are aimed at overcoming these limitations. sponse to serotonin and prostaglandin stimulation in BIODEGRADABLE SCAFFOLDS FOR vitro. To assess in vivo performance, vascular constructs VASCULAR TISSUE ENGINEERING made of porcine SMC and EC were implanted in minipigs. Digital angiography at different time points was Several reports in the literature describe the use of different biomaterials, either of natural origin, like de-performed and documented patency of pulsed grafts for up to 4 weeks.
cellularized matrices or collagen sponges, or synthetic products, like PGA, polycaprolactone (PCL), and other A different approach was that followed by Kaushal VASCULAR TISSUE ENGINEERING S121 polymers. The main advantages related to the use of nat-myofibroblast, cultured for 1 week, and implanted in the inferior vena cava of the same dog from which cells ural acellular tissue are the intrinsic cell compatibility and adequate mechanical properties, due to material were obtained. Tensile tests performed on the scaffold without cells demonstrated that the properties of the ma-composition. The presence of ECM proteins can in fact support cellular attachment and growth, and provides the terial degraded in only 1 week, and explanted grafts, after 6 months, showed no sign of stenosis or aneurismal desired elasticity and mechanical strength. On the other hand, natural tissues need to be treated with chemicals change, even in the absence of an endothelial layer and without the use of anticoagulants. Another interesting to neutralize cellular components and may activate host immune response with risk of patient sensibilization study based on a synthetic biomaterial is that of Hoerstrup and coworkers (12). In this work myofibroblasts (28). Among natural materials, collagen matrices were also used in several studies. A recent work of Berglund and endothelial cells isolated from segments of ovine carotid were seeded onto tubes made of a copolymer of and colleagues (3) reports on a TEBV based on a crosslinked collagen sleeve, used as mechanical support, sur-PGA and P4HB and cultured in a bioreactor. Mechanical properties of these constructs improved with culture rounded by collagen hydrogel containing vascular SMCs. The presence of a biological sleeve provided temporary time in the presence of mechanical stimulation. However, despite the variety of biomaterials described in the mechanical support while cell-mediated remodeling of the construct occurred, afterwards degrading over time.
literature, these materials do not possess the required properties, mainly elasticity that characterizes native The results obtained showed that this method allowed to obtain a vessel with higher strength compared to colla-vessels, and adequate compatibility with vascular cells. In addition, the major limitation in the development of gen gels alone but still weaker then native arteries. Another material obtained from a biological molecule is new synthetic biodegradable materials is the approval from public agencies for clinical use. This process is HYAFF, a benzilic ester of hyaluronic acid. This material, approved for clinical use, is routinely implanted time consuming and very expensive and is becoming an obstacle in development of new materials. for skin and cartilage reconstruction. In the field of vascular tissue engineering we recently reported (26) the THE USE OF BIOREACTORS possibility of generating a vascular construct starting from cellularized flat sheets made of nonwoven HYAFF It has been suggested by several research groups that maturation of vascular constructs must be carried out in rolled over a mandrel, as shown in Figure 1 . SMC showed a good affinity with the scaffold material and matrix vitro in the presence of a physical stimulation similar to that present in native arteries. To this purpose cell production was detected. However, mechanical and histological properties of the constructs are still far from bioreactors have been developed to subject vascular constructs to radial dilatation or fluid flow with pulsatile those of natural arteries.
Among synthetic materials, PGA is the more fre-pressure. One of the first examples of these devices was that described by Seliktar and coworkers (29) that was quently used, together with PCL and polyhydroxybutyrate (P4HB). In 2001 Watanabe and colleagues (36) based on a pulsatile pressure generated inside a silicone sleeve surrounded by a collagen gel seeded with SMCs. published a study reporting successful generation of a tissue engineered autograft, based on PCL seeded with Bioreactors developed by Sodian et al. (33) and by The values of shear stress im-type of mechanical stimulation imposed to vascular constructs. Fluid flow was directly applied to the developing posed on the endothelial layer matched physiological range and applied pressure was variable between normal constructs, submitting them to physiological luminal shear stress and radial pressure, enhancing nutrient and systolic and diastolic values. Mechanical stimulation allowed to obtain stronger constructs with higher ECM oxygen delivery. The device described by Sodian and coworkers was driven by a mechanical ventilator that content compared with respective controls. The comparison with native arteries showed that bioartificial vessels generated a sinusoidal pressure wave, transmitted to culture medium by a silicon membrane. Seeding of vascular had comparable strength but significantly lower elasticity. Looking at these results, it can be observed that all cells onto the tubular scaffold was performed in the same chamber used for perfusion, thus limiting the risks the developed devices are able to mimic the in vivo conditions, in terms of shear stress and pressure applied. It of contamination. Thompson and colleagues developed a perfusion bioreactor composed of a closed circuit with remains to be further investigated which conditions of mechanical stimulation can lead to engineered constructs an oxygenator to provide oxygen to the circulating culture medium. The pressure was generated by a mechani-with properties equivalent to that of native vessel. cal ventilator and the presence of valves and compliant CELLULAR SOURCES FOR VASCULAR tubing allowed to obtain a pressure wave similar to TISSUE ENGINEERING physiological aortic waveforms. The results showed that the device successfully supported growth and maturation Regarding cellular sources for vascular tissue engineering, the most recent studies investigated the possi-of vascular constructs. Recently Williams and coworkers (38) developed a perfusion bioreactor in which cell bility of using alternative sources to differentiated vascular cells, to avoid the need of surgical harvest of seeding and mechanical stimulation of the vascular construct were performed. Seeding of cells onto the polymer autologous vessel segments. There are two different solutions in this regard. Some investigators have focused was achieved by means of a dual syringe pump that pumped the cell suspension reciprocally through the lu-on genetically modified SMC that can proliferate faster and for a longer time than untreated cells (22, 34) ; others men of the scaffold. After cell seeding, fluid flow was applied to the vascular construct, both through the vessel are attempting to use stem cells, like bone marrow stromal cells (BMSC) (5, 16, 20) or endothelial and smooth lumen and in the direction perpendicular to construct longitudinal axis, to further increase nutrient and oxygen muscle progenitor cells (14,39).
McKee and coworkers (22) hypothesized that the supply. Constructs developed with the bioreactor showed that cells were distributed uniformly, mainly on the lu-limiting factor that prevents in vitro engineering of a blood vessel is the limited proliferative capacity of adult minal surface, demonstrating the efficiency of this seeding method. In constructs harvested after 25 days of cul-SMC. They therefore developed a method to avoid SMC ageing, infecting the cells with a retroviral vector encod-ture, cells heavily colonized the external regions of construct wall, stained positively for α-smooth muscle ing for human telomerase reverse transcriptase subunit (hTERT) that has the ability to elongate cell telomeres, actin (αSMA) and calponin and some amount of elastin was detected.
extending cell life span. Genetically modified cells were phenotypically normal, expressing calponin, smooth Another recent example of a new bioreactor was reported by McCulloch and coworkers (21). This device muscle heavy chain, and elastin. When seeded onto PGA mesh and cultured within a bioreactor, hTERT applies radial pressure and fluid flow to the vascular construct and stretches the vessel in the longitudinal di-SMC allowed to obtain a vessel with larger wall thickness, increased strength, and decreased apoptosis, com-rection. The system used to generate physiological pressure and flow waveforms is composed by a computer-pared to control nontransfected cells. A different approach was that followed by Stegemann and colleagues controlled pulsatile pump, connected to the chamber that contains the vascular construct and to a reservoir with an (34), who attempted to avoid SMC dedifferentiation with culture passages. They investigated SMC transfec-inlet valve that emulates systemic resistance. The straininducing system was composed of a rack-and-pinion tion with a gene that encoded for phenotype regulating protein cyclic guanosine monophospate-dependent pro-mechanism driven by a precision stepper motor, fastened to a tissue holder. Functional tests confirmed the tein kinase (PKG). This protein is able to increase the levels of αSMA, driving SMC phenotype towards a possibility to obtain the desired mechanical outputs and to support constructs maturation. The group of Optiz and more physiologic contractile phenotype. PKG transfected cells in monolayer cultures showed a higher expres-coworkers recently reported studies (24,25) on the development of a TEBV, based on P4HB scaffold and sion of αSMA compared to control SMCs, but the collagen gels obtained using transfected cells were not ovine SMC and EC. The maturation of the constructs VASCULAR TISSUE ENGINEERING S123 significantly different from controls in terms of com-Shirota and colleagues (31) described a small-diameter vascular graft obtained from EPC seeded onto a polyure-pactness and cellularity. Mechanical (radial pressure) and biochemical (PDGF and TGF-β) stimulation thane scaffold. EPC demonstrated to be highly proliferative, to possess antithrombogenic properties, and to re-showed different effects on control and PKG transfected gels. In the latter the addition of PDGF did not result in spond to shear stress. Recently, Simper and colleagues (7,32) identified SM progenitor cells (SMPC) in periph-lower expression of contractile proteins as in controls, demonstrating a steady differentiated phenotype of treated eral blood and expanded them ex vivo. Immunofluorescence staining showed that SMPCs were positive for cells.
Regarding stem cells, there are already in the litera-αSMA, myosin heavy chain, and calponin, and adhesion tests demonstrated their ability to adhere to fibronectin-ture approaches that focuses on the use of BMSC for vascular tissue engineering. As reported in several stud-coated surface. All these findings showed that progenitor cells could potentially be used for the generation of ies, it is possible to differentiate these cells into SMCs (8, 13, 27 ). The first report on BSMC to regenerate blood engineered blood vessel segments. A completely different approach regarding cell source vessels in vivo is that of Matsumura and colleagues (20) . In this study, BMSCs were extracted from canine bone was reported in the work of Campbell and coworkers (4, 6) , who investigated the possibility to induce in vivo marrow and treated with a fluorescent cell tracker, prior to seeding onto PCL scaffolds. A cellularized scaffold regeneration of cylindrical cell construct. Their method consisted of the insertion of a polymeric tube in the peri-was then implanted into the same dog and immunofluorescence staining was performed at harvesting. Results toneal cavity of a dog. The presence of a foreign material in the body caused the formation of a fibrotic tissue demonstrated that BMSCs adhered to the scaffold and differentiated into either endothelial or smooth muscle around the mandrel. This tissue was then harvested and characterized. The amount of tissue formation depended cells, as confirmed by the presence of cells positive for specific endothelial or smooth muscle markers and si-on the type of synthetic material used, and cells included in the tissue were positive for early differentiation SMC multaneously for the cell tracker. The vascular grafts remained patent for the entire implantation period and markers (β-actin, vimentin) but not for more specific markers (myosin and elastin). Burst strength of the con-were colonized also from host cells. Moreover, generation of physiological components of the vessel wall, structs was higher than 2500 mmHg and, when transplanted in dogs, the grafts showed no sign of aneurysm such as elastic laminae and circumferentially aligned collagen fibers, was observed. In 2005 Cho and cowork-nor intimal thickening. Three months after implantation the formation of a physiological layered structure was ers (5) reported engineering of a vascular graft using predifferentiated BMSCs seeded onto decellularized observed in the harvested graft, with smooth muscle cells in the middle and a luminal endothelial layer. All vascular matrix. BMSCs were isolated from dogs, marked with a cell tracker, and differentiated in vitro in these studies demonstrate that next generation of bioartificial vessels may effectively be obtained without the either SMC or EC, with appropriate growth factors in the culture medium. Successful cell differentiation to-use of differentiated vascular cells. wards a SMC phenotype was confirmed by positive CLINICAL APPLICATIONS staining for αSMA and myosin heavy chain, while en-OF BIOARTIFICIAL VESSELS dothelial differentiation was demonstrated by CD31 and von Willebrand factor expression. After 1 week of in Despite numerous successful studies at the experimental level, the transfer of these findings to the clinic vitro culture, vascular constructs were implanted in vivo. Analysis on explanted grafts showed that the internal has not yet started. There are only a few reports in the literature of successful use of tissue engineering in vas-surface was uniformly covered with endothelial cells, derived also from the host, that ensure patency to the cular surgery. The first clinical application of a biodegradable scaffold seeded with cells was reported by vascular grafts. In vitro seeded BMSCs were still present, as confirmed by fluorescence detection.
Shin'oka and colleagues in 2001 (30) . Cells isolated from a peripheral vein were seeded onto a PCL-PLLA Another innovative cellular source suitable for vascular tissue engineering is represented by EPC. These cells scaffold and implanted in a 4-year-old girl, to substitute a tract of pulmonary artery. Seven months after interven-can be isolated from peripheral blood, thus avoiding invasive surgical procedures; they can differentiate in cells tion the patient had no complications and the graft was still patent and without aneurysm. In a second report by with endothelial and also mesenchymal phenotype (9, 39). In the previously mentioned work by Kaushal and the same group (19) , they reported the application of a tissue engineered autograft based on either SMC from coworkers (14), these cells were seeded onto decellularized matrices, allowing to obtain grafts that were patent saphenous vein or BMSC from bone marrow seeded onto the same polymeric scaffold. In the first procedure for the entire experimental period. The study reported by
